MAPT and Alzheimer disease: This mechanism has the ability to interact with other pathological aspects of AD, such as aberrant Aβ and tau cascade, inflammation, apoptosis, and imbalances in neurotransmitter and neurohormonal systems (Wang and Zhang, 2018).